GC
AGTC

Globeflex Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Globeflex Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-124,514
Closed -$1.16M – 574
2016
Q4 		$1.16M Buy
124,514
+53,900
+76% +$485K 0.29% 131
2016
Q3 		$691K Buy
70,614
+60
+0.1% +$809 0.17% 212
2016
Q2 		$997K Buy
+70,554
New +$1.1M 0.27% 136
2016
Q1 		– Sell
-58,300
Closed -$1.19M – 509
2015
Q4 		$1.19M Buy
+58,300
New +$899K 0.32% 104

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Globeflex Capital's AGTC Position: Q1 2017 in Review

Globeflex Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 124,514 shares — an estimated $1.16M sold.

Globeflex Capital first reported a position in AGTC in Q4 2015 and held it in 4 quarters. The position peaked at $1.19M in Q4 2015. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

  • Globeflex Capital reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
  • Globeflex Capital sold 124,514 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $1.16M.
  • Globeflex Capital first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 4 quarters.
  • Globeflex Capital's Applied Genetic Technologies Corporation position peaked at $1.19M in Q4 2015.
  • 89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.